GLISAXAPIN M 5/500:Uses, Side Effects,Benefits, Dosage & More...

GLISAXAPIN M 5/500

Saxagliptin (5mg), Metformin HCI (ER) (500mg)

GLISAXAPIN M 5/500 combination of Saxagliptin (5mg) and Metformin HCI (ER) (500mg) combine in GLISAXAPIN M 5/500 to offer a comprehensive approach to managing type 2 diabetes mellitus. In this article, we'll explore the synergistic benefits, mechanism of action, therapeutic uses, potential side effects, and considerations associated with GLISAXAPIN M 5/500 therapy.

Understanding GLISAXAPIN M 5/500:

• Saxagliptin (5mg): Saxagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances insulin secretion and decreases glucagon levels, thereby improving glycemic control.

• Metformin HCI (ER) (500mg): Metformin HCI (ER) reduces hepatic glucose production, enhances peripheral glucose uptake, and improves insulin sensitivity, contributing to lower blood glucose levels.

Benefits of GLISAXAPIN M 5/500:

• Dual Action: GLISAXAPIN M 5/500 offers a dual mechanism of action, targeting both insulin secretion and insulin resistance to achieve optimal glycemic control.

• Stable Blood Glucose Levels: By combining Saxagliptin and Metformin HCI, GLISAXAPIN M 5/500 helps maintain stable blood glucose levels throughout the day.

Therapeutic Uses:

• Combination Therapy: It can be used alone or in combination with other antidiabetic medications to achieve target blood glucose levels.

Considerations for Use:

• Renal Function Monitoring: Regular monitoring of renal function is essential during GLISAXAPIN M 5/500 therapy due to the presence of Metformin HCI. 

• Adherence to Treatment Plan: Patients should adhere to the prescribed dosage and administration schedule to maximize the benefits of GLISAXAPIN M 5/500 and minimize the risk of adverse effects.

Potential Side Effects:

• Gastrointestinal Upset: Common side effects of GLISAXAPIN M 5/500 may include nausea, vomiting, diarrhea, and abdominal discomfort. These effects are usually transient and can be minimized by taking the medication with meals.

Conclusion:

GLISAXAPIN M 5/500, combining Saxagliptin (5mg) and Metformin HCI (ER) (500mg), offers a valuable treatment option for individuals with type 2 diabetes mellitus. By understanding its mechanism of action, therapeutic benefits, and considerations for use, healthcare providers can optimize the use of GLISAXAPIN M 5/500 to improve glycemic control and enhance patient outcomes.Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

For further information: 

EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

CALL/WHATSAPP: 7877551268, 7849827488

BUY NOW